Loading...
OTCM
BLGO
Market cap36mUSD
Jul 09, Last price  
0.11USD
1D
-1.11%
1Q
-20.24%
Jan 2017
-86.13%
Name

BioLargo Inc

Chart & Performance

D1W1MN
OTCM:BLGO chart
P/E
—
P/S
4.74
EPS
—
Div Yield, %
—
Shrs. gr., 5y
9.39%
Rev. gr., 5y
26.13%
Revenues
8m
-56.32%
080,0000138,133156,761156,18965,542167,946111,547127,582281,106516,2131,364,0001,861,0002,432,0002,531,0005,884,00012,230,00017,779,0007,765,000
Net income
-12m
L+390.42%
-1,310,706-5,259,390-7,142,750-15,612,532-5,742,341-3,954,389-5,333,986-2,528,323-3,692,116-5,055,976-7,839,731-9,117,304-10,221,000-14,749,000-10,466,000-7,377,000-4,496,000-3,504,000-2,402,000-11,780,000
CFO
-8m
L+158.80%
-1,315,628-1,287,525-1,899,034-1,369,394-1,296,556-1,716,324-2,032,804-1,212,252-1,718,621-1,883,342-3,720,912-4,283,015-3,891,000-4,422,000-4,154,000-3,937,000-2,762,000-2,365,000-3,206,000-8,297,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater purification, managing industrial odors and volatile organic compounds (VOCs), enhancing air quality, and controlling infections. Backed by numerous issued patents, BioLargo maintains a robust product pipeline and extends its expertise through comprehensive environmental engineering services. Among its notable innovations are the Advanced Oxidation system, a water treatment solution generating potent oxidative and energetic iodine species; the Aqueous Electrostatic Concentrator, specifically designed for eliminating PFAS from water; CupriDyne Clean industrial products, which effectively neutralize stubborn odors and VOCs across various industrial settings; and specialized advanced wound care products. Established in 1991, BioLargo, Inc. is headquartered in Westminster, California.
URL
https://www.biolargo.com/
IPO date
Dec 12, 1991
Employees
32
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT